Aptus Endosystems, a Baird Venture Partners portfolio company, Completes $30 Million Series C Financing

 
January 7, 2009
 
Aptus Endosystems Inc., a medical device company developing advanced technology for the endovascular treatment of aortic aneurysms, today announced it has closed a $30 Million Series C financing.

Read the full article
 
For additional information contact:
 
 
Aptus Endosystems, Inc.
Bob H. Katz,
President & CEO
Ph. 408-530-9050, ext. 303
 
 
Careers|Help|Site Map|Important Disclosures|Privacy Policy|Code of Conduct|Financial Information|Business Continuity
©2010 Robert W. Baird & Co. Incorporated.
The services featured on this Web site may not be available in all jurisdictions or to all persons/entities. For more information, please see Important Disclosures. Robert W. Baird & Co. Incorporated. Member SIPC.